menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Fresenius Receives FDA Approval for their Denosumab Biosimilars

    BUSINESSWIRE

    Fresenius Kabi Launches Calcitonin Salmon Injection

    BUSINESSWIRE

    Fresenius Kabi`s Biologic Otulfi (Ustekinumab) Receives Approval in US

    FDA

    Fresenius Kabi`s Generics Pantoprazole Sodium Receives Approval in US

    FDA

    Fresenius Kabi USA`s Generics Daptomycin Receives Approval in US

    FDA

    Fresenius Kabi Usa Generic Sodium Chloride Receives Approval in US

    FDA

    Fresenius Kabi USA Wins Drug Shortage Guardian Award

    BUSINESSWIRE

    Fresenius Kabi Usa`s Generic Adalimumab-Aacf Receives Approval in US

    FDA

    Fresenius Kabi USA`s Idacio (adalimumab-aacf) Receives Suppl Approval in the U.S.

    FDA

    Fresenius Kabi USA Generic Verapamil Hydrochloride Receives Approval in the U.S.

    FDA

    Fresenius`s Biologic Stimufend (Pegfilgrastim) Receives Approval in the U.S.

    FDA

    Fresenius Kabi USA`s Generic Posaconazole Receives Tentative Approval in the U.S.

    FDA

    Fresenius USA`s Posaconazole Generic Pirfenidone Receives TentativeApproval U.S.

    FDA

    Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa

    BUSINESSWIRE

    Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Inj.

    BUSINESSWIRE

    Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent

    BUSINESSWIRE

    Fagron expands its US sterile compounding footprint with East coast acquisition

    GLOBENEWSWIRE

    Fresenius Kabi USA`s Generic Kabilyte Receives Approval in the US

    FDA

    Fresenius Kabi Introduces New Generic for Non-Squamous NSCLC

    BUSINESSWIRE

    Dr. Brandee Pappalardo Joins Fresenius Kabi as CMO for N. America

    BUSINESSWIRE

    Toxins In Silicone Tubing Leads To FDA Warning

    MEDTECH INSIGHT

    Fresenius Kabi USA Generic Bortezomib Receives Approval in the U.S.

    FDA

    Fresenius Kabi Introduces New Generic for the Treatment of Multiple Myeloma

    BUSINESSWIRE

    Fresenius Kabi Introduces Calcium Gluconate in Sodium Chloride Injection

    BUSINESSWIRE

    Fresenius Kabi USA,`s Generic Sodium Phosphate Receives Approval in the U.S.

    FDA

    Fresenius Sues Zydus Over Patents for Rare Thyroid Disease Drug

    BLOOMBERGLAW

    Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP

    BUSINESSWIRE

    Fresenius & Phlow Corp. Form Alliance to Enhance Supply of Essential Medicines

    BUSINESSWIRE

    FDA Issues Form 483 to Fresenius Kabi USA LLC

    FDA

    Recall report: Fresenius Kabi yanks inflammatory med Ketorolac after finding

    ENDPTS

    Fresenius Kabi USA`s Generic Succinylcholine Chloride Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Potassium Cl: Sodium Cl Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Dextrose: Sodium Chloride Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Dextrose: Sodium Chloride Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Dextrose: Sodium Chloride Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Dextrose Potassium Chloride Receives Approval In US

    FDA

    Fresenius Kabi`s Generic Potassium Chloride Receives Approval In US

    FDA

    Fresenius Kabi`s Generic Potassium Chloride Receives Approval In US

    FDA

    Fresenius Kabi`s Generic Potassium Chloride Receives Approval In US

    FDA

    Fresenius Kabi Introduces RFID Smart Labels for Essential Meds

    CONTRACTPHARMA

    Fresenius Kabi`s Generic Oxacillin SodiumReceives Approval in US

    FDA

    Fresenius Kabi Adds Micafungin for Inj to Expanding Anti-Infective Portfolio

    BUSINESSWIRE

    Fresenius Kabi`s Generic Dextrose and Sodium Chloride Receives Approval in US

    FDA

    Fresenius Kabi Introduces Heparin Sodium Injection

    BUSINESSWIRE

    Enforcement Report - Week of July 24, 2019

    FDA

    FRESENIUS KABI USA`s generic HALOPERIDOL LACTATE Receives Approval in US

    FDA

    Fresenius Kabi`s Generic Micafungin Sodium Receives Approval in US

    FDA

    Fresenius Kabi`s Generic Fentanyl Citrate Receives Approval in US

    FDA

    Fresenius Kabi`s Generic Sodium Chloride Receives Approval in US

    FDA

    Fresenius Kabi`s Generic Phenylephrine HCl (ANDA 210666) Receives Approval in US

    FDA

    Fresenius Kabi`s Generic Phenylephrine HCl (ANDA 210665) Receives Approval in US

    FDA

    Fresenius Kabi USA`s Generic Dicyclomine Hydrochloride Receives Approval in US

    FDA

    Enforcement Report - Week of December 12, 2018

    FDA

    Enforcement Report - Week of December 5, 2018

    FDA

    Special 510(k)s: CDRH’s Proposed Program Expansion Draws Mixed Reactions

    RAPS

    Fresenius Kabi`s Generic Dexmedetomidine Hydrochloride Receives Approval in US

    FDA

    AbbVie settles Humira biosimilar dispute with Fresenius Kabi

    REUTERS

    Fresenius Kabi USA`s Generic Palonosetron Hydrochloride Receives Approval in US

    FDA

    Fresenius Kabi USA`s Generic Arsenic Trioxide Receives Approval in US

    FDA

    Fresenius Kabi USA`s Generic Posaconazole Receives Tentative Approval in US

    FDA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.